Efficacy of a synthetic pentasac-charide, a pure factor Xa inhibitor, as an antithrombotic agent--a pilot study in the setting of coronary angioplasty - Vuillemenot, A; Schiele, F; Meneveau, N (Thromb Haemost, 1999)
et al.